DJ Biogen Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ shed 1.17% to $187.06 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.29% to 7,230.12 and the Dow Jones Industrial Average falling 0.31% to 49,499.27.
This was the stock's second consecutive day of losses.
Biogen Inc. closed 7.58% short of its 52-week high of $202.41, which the company reached on February 6th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 1.16% to $227.19, Pfizer Inc. $(PFE)$ fell 1.39% to $26.33, and AbbVie Inc. $(ABBV)$ fell 2.23% to $206.60.
Trading volume (696,648) remained 446,694 below its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 1, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 01, 2026 17:00 ET (21:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments